FDA Inspection
PureTek CorporationPureTek Corporation – FDA Inspection, Mar 7, 2025
Record Details
This FDA Inspection record concerns PureTek Corporation, with an inspection on March 7, 2025, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 24ebf089-ae01-4668-a6fd-05bdc2dda206
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1262436
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.122(d)Label storage access limited to authorized personnel
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PureTek Corporation
9| Date | Classification | Office | Project area |
|---|---|---|---|
| January 30, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2015 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| March 18, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PureTek Corporation
- FDA Inspection 1116761 - 2020-01-30
- FDA Inspection 1034952 - 2017-12-15
- FDA Inspection 949735 - 2015-10-27
- FDA Inspection 919565 - 2015-03-18
- FDA Inspection 860979 - 2013-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.